Skip to content
naulon
Not checkedNot checked for notices yet.

The effects of gender-affirming hormone therapy on cardiovascular and skeletal health: A literature review

Nyein Chan Swe, Samihah Ahmed, Marwen Eid and 3 more

Metabolism Open · 2022

doi:10.1016/j.metop.2022.100173 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Approximately 1.5 million people in the United States currently identify as transgender. The use of gender affirming hormone therapy is integral to routine clinical care of transgender individuals, yet our understanding of the effects of this therapy is limited. There are reasons to believe that gender affirming hormone therapy may have important effects on cardiovascular risk and bone health in transgender individuals. The purpose of this review article is to summarize the evidence for the cardiovascular effects (including coronary artery disease, hypertension and stroke) as well as the effects on bone metabolism associated with gender affirming hormone therapy in both transgender men and transgender women.

Abstract licence: CC BY-NC

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.